Skip to main content

Naproxen

NDC 52817-381 · TruPharma LLC

Generic nameNaproxen
Dosage formTABLET, DELAYED RELEASE
RouteORAL
Active ingredient(s)NAPROXEN
Strength500 mg/1
Pharmacologic classAnti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
Marketing categoryANDA

Packages

52817-381-10 — 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (52817-381-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50228-437 — Naproxen and esomeprazole magnesium, 50228-438 — Naproxen and esomeprazole magnesium, 50268-594 — Naproxen, 50268-595 — Naproxen, 51655-363 — Naproxen, 51655-457 — Naproxen, 51655-621 — NAPROXEN, 51655-657 — Naproxen, 51655-743 — Naproxen, 52817-380 — Naproxen, 53746-188 — Naproxen, 53746-189 — Naproxen, 53746-190 — Naproxen, 55111-289 — Naproxen and esomeprazole magnesium, 55111-701 — Naproxen and esomeprazole magnesium, 55700-888 — Naproxen, 59651-528 — Naproxen, 59651-986 — Naproxen, 59651-987 — Naproxen, 60687-491 — Naproxen, +171 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels